Uncovering the Bioactive Potential of a Cyanobacterial Natural Products Library Aided by Untargeted Metabolomics

The Blue Biotechnology and Ecotoxicology Culture Collection (LEGE-CC) holds a vast number of cyanobacteria whose chemical richness is still largely unknown. To expedite its bioactivity screening we developed a natural products library. Sixty strains and four environmental samples were chromatographe...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Leonor Ferreira, João Morais, Marco Preto, Raquel Silva, Ralph Urbatzka, Vitor Vasconcelos, Mariana Reis
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
Acceso en línea:https://doaj.org/article/7bb6d77e420544109d44cc5b253900c5
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:7bb6d77e420544109d44cc5b253900c5
record_format dspace
spelling oai:doaj.org-article:7bb6d77e420544109d44cc5b253900c52021-11-25T18:12:57ZUncovering the Bioactive Potential of a Cyanobacterial Natural Products Library Aided by Untargeted Metabolomics10.3390/md191106331660-3397https://doaj.org/article/7bb6d77e420544109d44cc5b253900c52021-11-01T00:00:00Zhttps://www.mdpi.com/1660-3397/19/11/633https://doaj.org/toc/1660-3397The Blue Biotechnology and Ecotoxicology Culture Collection (LEGE-CC) holds a vast number of cyanobacteria whose chemical richness is still largely unknown. To expedite its bioactivity screening we developed a natural products library. Sixty strains and four environmental samples were chromatographed, using a semiautomatic HPLC system, yielding 512 fractions that were tested for their cytotoxic activity against 2D and 3D models of human colon carcinoma (HCT 116), and non-cancerous cell line hCMEC/D3. Six fractions showed high cytotoxicity against 2D and 3D cell models (group A), and six other fractions were selected by their effects on 3D cells (group B). The metabolome of each group was organized and characterized using the MolNetEnhancer workflow, and its processing with MetaboAnalyst allowed discrimination of the mass features with the highest fold change, and thus the ones that might be bioactive. Of those, mass features without precedented identification were mostly found in group A, indicating seven possible novel bioactive molecules, alongside in silico putative annotation of five cytotoxic compounds. Manual dereplication of group B tentatively identified nine pheophytin and pheophorbide derivatives. Our approach enabled the selection of 7 out of 60 cyanobacterial strains for anticancer drug discovery, providing new data concerning the chemical composition of these cyanobacteria.Leonor FerreiraJoão MoraisMarco PretoRaquel SilvaRalph UrbatzkaVitor VasconcelosMariana ReisMDPI AGarticlenatural products librarycyanobacteriacytotoxicity3D spheroidsuntargeted metabolomicsMetaboAnalystBiology (General)QH301-705.5ENMarine Drugs, Vol 19, Iss 633, p 633 (2021)
institution DOAJ
collection DOAJ
language EN
topic natural products library
cyanobacteria
cytotoxicity
3D spheroids
untargeted metabolomics
MetaboAnalyst
Biology (General)
QH301-705.5
spellingShingle natural products library
cyanobacteria
cytotoxicity
3D spheroids
untargeted metabolomics
MetaboAnalyst
Biology (General)
QH301-705.5
Leonor Ferreira
João Morais
Marco Preto
Raquel Silva
Ralph Urbatzka
Vitor Vasconcelos
Mariana Reis
Uncovering the Bioactive Potential of a Cyanobacterial Natural Products Library Aided by Untargeted Metabolomics
description The Blue Biotechnology and Ecotoxicology Culture Collection (LEGE-CC) holds a vast number of cyanobacteria whose chemical richness is still largely unknown. To expedite its bioactivity screening we developed a natural products library. Sixty strains and four environmental samples were chromatographed, using a semiautomatic HPLC system, yielding 512 fractions that were tested for their cytotoxic activity against 2D and 3D models of human colon carcinoma (HCT 116), and non-cancerous cell line hCMEC/D3. Six fractions showed high cytotoxicity against 2D and 3D cell models (group A), and six other fractions were selected by their effects on 3D cells (group B). The metabolome of each group was organized and characterized using the MolNetEnhancer workflow, and its processing with MetaboAnalyst allowed discrimination of the mass features with the highest fold change, and thus the ones that might be bioactive. Of those, mass features without precedented identification were mostly found in group A, indicating seven possible novel bioactive molecules, alongside in silico putative annotation of five cytotoxic compounds. Manual dereplication of group B tentatively identified nine pheophytin and pheophorbide derivatives. Our approach enabled the selection of 7 out of 60 cyanobacterial strains for anticancer drug discovery, providing new data concerning the chemical composition of these cyanobacteria.
format article
author Leonor Ferreira
João Morais
Marco Preto
Raquel Silva
Ralph Urbatzka
Vitor Vasconcelos
Mariana Reis
author_facet Leonor Ferreira
João Morais
Marco Preto
Raquel Silva
Ralph Urbatzka
Vitor Vasconcelos
Mariana Reis
author_sort Leonor Ferreira
title Uncovering the Bioactive Potential of a Cyanobacterial Natural Products Library Aided by Untargeted Metabolomics
title_short Uncovering the Bioactive Potential of a Cyanobacterial Natural Products Library Aided by Untargeted Metabolomics
title_full Uncovering the Bioactive Potential of a Cyanobacterial Natural Products Library Aided by Untargeted Metabolomics
title_fullStr Uncovering the Bioactive Potential of a Cyanobacterial Natural Products Library Aided by Untargeted Metabolomics
title_full_unstemmed Uncovering the Bioactive Potential of a Cyanobacterial Natural Products Library Aided by Untargeted Metabolomics
title_sort uncovering the bioactive potential of a cyanobacterial natural products library aided by untargeted metabolomics
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/7bb6d77e420544109d44cc5b253900c5
work_keys_str_mv AT leonorferreira uncoveringthebioactivepotentialofacyanobacterialnaturalproductslibraryaidedbyuntargetedmetabolomics
AT joaomorais uncoveringthebioactivepotentialofacyanobacterialnaturalproductslibraryaidedbyuntargetedmetabolomics
AT marcopreto uncoveringthebioactivepotentialofacyanobacterialnaturalproductslibraryaidedbyuntargetedmetabolomics
AT raquelsilva uncoveringthebioactivepotentialofacyanobacterialnaturalproductslibraryaidedbyuntargetedmetabolomics
AT ralphurbatzka uncoveringthebioactivepotentialofacyanobacterialnaturalproductslibraryaidedbyuntargetedmetabolomics
AT vitorvasconcelos uncoveringthebioactivepotentialofacyanobacterialnaturalproductslibraryaidedbyuntargetedmetabolomics
AT marianareis uncoveringthebioactivepotentialofacyanobacterialnaturalproductslibraryaidedbyuntargetedmetabolomics
_version_ 1718411505022533632